MedTrace Logo

Blood Glucose Monitoring Systems: Discounter Versus Brand

NCT05031000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2021-10-14

No results posted yet for this study

Summary

This study assesses the system accuracy of 5 blood glucose monitoring systems pursuant to ISO 15197 under the aspect of the system's prospected costs for the user.

Conditions

Interventions

DIAGNOSTIC_TEST

blood glucose measurement: POCT

measurement of blood glucose concentration using 5 different POCT glucometer

DIAGNOSTIC_TEST

blood glucose measurement: reference

measurement of blood glucose concentration using 2 different laboratory analyzer

Sponsors & Collaborators

  • Institut fur Diabetes Karlsburg GmbH

    lead OTHER

Principal Investigators

  • Eckhard Salzsieder, PhD · Institut fur Diabetes Karlsburg GmbH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-03
Primary Completion
2021-10-06
Completion
2021-10-06

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031000 on ClinicalTrials.gov